Roche Molecular Systems, Inc.
4300 Hacienda Drive
Roche Molecular Diagnostics (operating in the US as Roche Molecular Systems) develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies. With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD’s clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.
The business, headquartered in Pleasanton, California, was founded in the early 1990s following the acquisition of the revolutionary, Nobel-prize winning Polymerase Chain Reaction Technology (PCR). PCR quickly replicates a single specific fragment of DNA or RNA to quantities sufficient for accurate laboratory analysis.
Roche Molecular Diagnostics is a business area of Roche Diagnostics (Basel, Switzerland) that employs around 1,000 people across three locations: Pleasanton, California; Branchburg, NJ; and Rotkreuz, Switzerland.
Centers of Excellence for Roche Molecular Systems
Branchburg (US): The largest polymerase chain reaction (PCR) manufacturing site in the world, supply chain, global customer support and quality
Pleasanton (US):: Headquarters, R&D, regulatory, clinical and medical affairs, business marketing and strategic marketing support
Rotkreuz (CH): Development and production of systems (instruments) and lab network solutions (software)
Roche Molecular Systems